These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 32041358)

  • 1. Displaced Myonuclei in Cancer Cachexia Suggest Altered Innervation.
    Daou N; Hassani M; Matos E; De Castro GS; Costa RGF; Seelaender M; Moresi V; Rocchi M; Adamo S; Li Z; Agbulut O; Coletti D
    Int J Mol Sci; 2020 Feb; 21(3):. PubMed ID: 32041358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Valproic acid attenuates skeletal muscle wasting by inhibiting C/EBPβ-regulated atrogin1 expression in cancer cachexia.
    Sun R; Zhang S; Hu W; Lu X; Lou N; Yang Z; Chen S; Zhang X; Yang H
    Am J Physiol Cell Physiol; 2016 Jul; 311(1):C101-15. PubMed ID: 27122162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cachexia does not induce loss of myonuclei or muscle fibres during xenografted prostate cancer in mice.
    Winje IM; Sheng X; Hansson KA; Solbrå A; Tennøe S; Saatcioglu F; Bruusgaard JC; Gundersen K
    Acta Physiol (Oxf); 2019 Mar; 225(3):e13204. PubMed ID: 30325108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular, cellular and physiological characterization of the cancer cachexia-inducing C26 colon carcinoma in mouse.
    Aulino P; Berardi E; Cardillo VM; Rizzuto E; Perniconi B; Ramina C; Padula F; Spugnini EP; Baldi A; Faiola F; Adamo S; Coletti D
    BMC Cancer; 2010 Jul; 10():363. PubMed ID: 20615237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genome-wide identification of FoxO-dependent gene networks in skeletal muscle during C26 cancer cachexia.
    Judge SM; Wu CL; Beharry AW; Roberts BM; Ferreira LF; Kandarian SC; Judge AR
    BMC Cancer; 2014 Dec; 14():997. PubMed ID: 25539728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of PARP activity in lung cancer-induced cachexia: Effects on muscle oxidative stress, proteolysis, anabolic markers, and phenotype.
    Chacon-Cabrera A; Mateu-Jimenez M; Langohr K; Fermoselle C; García-Arumí E; Andreu AL; Yelamos J; Barreiro E
    J Cell Physiol; 2017 Dec; 232(12):3744-3761. PubMed ID: 28177129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aerobic Exercise and Pharmacological Treatments Counteract Cachexia by Modulating Autophagy in Colon Cancer.
    Pigna E; Berardi E; Aulino P; Rizzuto E; Zampieri S; Carraro U; Kern H; Merigliano S; Gruppo M; Mericskay M; Li Z; Rocchi M; Barone R; Macaluso F; Di Felice V; Adamo S; Coletti D; Moresi V
    Sci Rep; 2016 May; 6():26991. PubMed ID: 27244599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aerobic and resistance training dependent skeletal muscle plasticity in the colon-26 murine model of cancer cachexia.
    Khamoui AV; Park BS; Kim DH; Yeh MC; Oh SL; Elam ML; Jo E; Arjmandi BH; Salazar G; Grant SC; Contreras RJ; Lee WJ; Kim JS
    Metabolism; 2016 May; 65(5):685-698. PubMed ID: 27085776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of the SDF1/CXCR4 pathway retards muscle atrophy during cancer cachexia.
    Martinelli GB; Olivari D; Re Cecconi AD; Talamini L; Ottoboni L; Lecker SH; Stretch C; Baracos VE; Bathe OF; Resovi A; Giavazzi R; Cervo L; Piccirillo R
    Oncogene; 2016 Dec; 35(48):6212-6222. PubMed ID: 27212031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Muscle and serum metabolomes are dysregulated in colon-26 tumor-bearing mice despite amelioration of cachexia with activin receptor type 2B ligand blockade.
    Lautaoja JH; Lalowski M; Nissinen TA; Hentilä J; Shi Y; Ritvos O; Cheng S; Hulmi JJ
    Am J Physiol Endocrinol Metab; 2019 May; 316(5):E852-E865. PubMed ID: 30860875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumour-derived leukaemia inhibitory factor is a major driver of cancer cachexia and morbidity in C26 tumour-bearing mice.
    Kandarian SC; Nosacka RL; Delitto AE; Judge AR; Judge SM; Ganey JD; Moreira JD; Jackman RW
    J Cachexia Sarcopenia Muscle; 2018 Dec; 9(6):1109-1120. PubMed ID: 30270531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac and skeletal muscles show molecularly distinct responses to cancer cachexia.
    Shum AM; Fung DC; Corley SM; McGill MC; Bentley NL; Tan TC; Wilkins MR; Polly P
    Physiol Genomics; 2015 Dec; 47(12):588-99. PubMed ID: 26395599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FoxP1 is a transcriptional repressor associated with cancer cachexia that induces skeletal muscle wasting and weakness.
    Neyroud D; Nosacka RL; Callaway CS; Trevino JG; Hu H; Judge SM; Judge AR
    J Cachexia Sarcopenia Muscle; 2021 Apr; 12(2):421-442. PubMed ID: 33527776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myofiber degeneration/regeneration is induced in the cachectic ApcMin/+ mouse.
    Mehl KA; Davis JM; Berger FG; Carson JA
    J Appl Physiol (1985); 2005 Dec; 99(6):2379-87. PubMed ID: 16288100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of CCAAT/Enhancer Binding Protein Beta in Muscle Satellite Cells Inhibits Myogenesis in Cancer Cachexia.
    Marchildon F; Lamarche É; Lala-Tabbert N; St-Louis C; Wiper-Bergeron N
    PLoS One; 2015; 10(12):e0145583. PubMed ID: 26709824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. STAT3 activation in skeletal muscle links muscle wasting and the acute phase response in cancer cachexia.
    Bonetto A; Aydogdu T; Kunzevitzky N; Guttridge DC; Khuri S; Koniaris LG; Zimmers TA
    PLoS One; 2011; 6(7):e22538. PubMed ID: 21799891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Skeletal muscle is enriched in hematopoietic stem cells and not inflammatory cells in cachectic mice.
    Berardi E; Aulino P; Murfuni I; Toschi A; Padula F; Scicchitano BM; Coletti D; Adamo S
    Neurol Res; 2008 Mar; 30(2):160-9. PubMed ID: 18397608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Necdin is expressed in cachectic skeletal muscle to protect fibers from tumor-induced wasting.
    Sciorati C; Touvier T; Buono R; Pessina P; François S; Perrotta C; Meneveri R; Clementi E; Brunelli S
    J Cell Sci; 2009 Apr; 122(Pt 8):1119-25. PubMed ID: 19339547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selumetinib Attenuates Skeletal Muscle Wasting in Murine Cachexia Model through ERK Inhibition and AKT Activation.
    Quan-Jun Y; Yan H; Yong-Long H; Li-Li W; Jie L; Jin-Lu H; Jin L; Peng-Guo C; Run G; Cheng G
    Mol Cancer Ther; 2017 Feb; 16(2):334-343. PubMed ID: 27599525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Excessive fatty acid oxidation induces muscle atrophy in cancer cachexia.
    Fukawa T; Yan-Jiang BC; Min-Wen JC; Jun-Hao ET; Huang D; Qian CN; Ong P; Li Z; Chen S; Mak SY; Lim WJ; Kanayama HO; Mohan RE; Wang RR; Lai JH; Chua C; Ong HS; Tan KK; Ho YS; Tan IB; Teh BT; Shyh-Chang N
    Nat Med; 2016 Jun; 22(6):666-71. PubMed ID: 27135739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.